Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sonya Marshall-Gradisnik

Showing results (11-20 of 83) with videos related to

Pageof 9
Sort By:
Clinical Ophthalmology (Auckland, N.Z.)|August 12, 2009
Vasoactive neuropeptides in clinical ophthalmology: An association with autoimmune retinopathy?Donald R Staines, Ekua W Brenu, Sonya Marshall-Gradisnik
Frontiers in Immunology|November 1, 2024
Meta-analysis of natural killer cell cytotoxicity in myalgic encephalomyelitis/chronic fatigue syndromeJames N Baraniuk, Natalie Eaton-Fitch, Sonya Marshall-Gradisnik
Frontiers in Immunology|November 19, 2019
Naltrexone Restores Impaired Transient Receptor Potential Melastatin 3 Ion Channel Function in Natural Killer Cells From Myalgic Encephalomyelitis/Chronic Fatigue Syndrome PatientsHelene Cabanas, Katsuhiko Muraki, Donald Staines, et al.
Asian Pacific Journal of Allergy and Immunology|July 9, 2018
Reduced glycolytic reserve in isolated natural killer cells from Myalgic encephalomyelitis/ chronic fatigue syndrome patients: A preliminary investigationThao Nguyen, Donald Staines, Samantha Johnston, et al.
Neuroimage. Clinical|August 11, 2020
Mapping of pathological change in chronic fatigue syndrome using the ratio of T1- and T2-weighted MRI scansKiran Thapaliya, Sonya Marshall-Gradisnik, Don Staines, et al.
Plos One|December 3, 2025
Immune transcriptomic changes in Australian Gulf War veteransNatalie Eaton-Fitch, Etianne Martini Sasso, Sonya Marshall-Gradisnik
Frontiers in Neuroscience|July 6, 2026
Disrupted glymphatic function and its relationship with sleep and cognitive impairment in ME/CFS assessed via DTI-ALPSKiran Thapaliya, Sonya Marshall-Gradisnik, Maira Inderyas, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 3, 2024
Illness presentation and quality of life in myalgic encephalomyelitis/chronic fatigue syndrome and post COVID-19 condition: a pilot Australian cross-sectional studyBreanna Weigel, Natalie Eaton-Fitch, Kiran Thapaliya, et al.
International Journal of Environmental Research and Public Health|October 23, 2021
Potential Implications of Mammalian Transient Receptor Potential Melastatin 7 in the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A ReviewStanley Du Preez, Helene Cabanas, Donald Staines, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 3, 2024
A pilot cross-sectional investigation of symptom clusters and associations with patient-reported outcomes in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Post COVID-19 ConditionBreanna Weigel, Natalie Eaton-Fitch, Kiran Thapaliya, et al.
Pageof 9

Showing results (11-20 of 83) with videos related to

Sort By:
Pageof 9
Clinical Ophthalmology (Auckland, N.Z.)|August 12, 2009
Vasoactive neuropeptides in clinical ophthalmology: An association with autoimmune retinopathy?Donald R Staines, Ekua W Brenu, Sonya Marshall-Gradisnik
Frontiers in Immunology|November 1, 2024
Meta-analysis of natural killer cell cytotoxicity in myalgic encephalomyelitis/chronic fatigue syndromeJames N Baraniuk, Natalie Eaton-Fitch, Sonya Marshall-Gradisnik
Frontiers in Immunology|November 19, 2019
Naltrexone Restores Impaired Transient Receptor Potential Melastatin 3 Ion Channel Function in Natural Killer Cells From Myalgic Encephalomyelitis/Chronic Fatigue Syndrome PatientsHelene Cabanas, Katsuhiko Muraki, Donald Staines, et al.
Asian Pacific Journal of Allergy and Immunology|July 9, 2018
Reduced glycolytic reserve in isolated natural killer cells from Myalgic encephalomyelitis/ chronic fatigue syndrome patients: A preliminary investigationThao Nguyen, Donald Staines, Samantha Johnston, et al.
Neuroimage. Clinical|August 11, 2020
Mapping of pathological change in chronic fatigue syndrome using the ratio of T1- and T2-weighted MRI scansKiran Thapaliya, Sonya Marshall-Gradisnik, Don Staines, et al.
Plos One|December 3, 2025
Immune transcriptomic changes in Australian Gulf War veteransNatalie Eaton-Fitch, Etianne Martini Sasso, Sonya Marshall-Gradisnik
Frontiers in Neuroscience|July 6, 2026
Disrupted glymphatic function and its relationship with sleep and cognitive impairment in ME/CFS assessed via DTI-ALPSKiran Thapaliya, Sonya Marshall-Gradisnik, Maira Inderyas, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 3, 2024
Illness presentation and quality of life in myalgic encephalomyelitis/chronic fatigue syndrome and post COVID-19 condition: a pilot Australian cross-sectional studyBreanna Weigel, Natalie Eaton-Fitch, Kiran Thapaliya, et al.
International Journal of Environmental Research and Public Health|October 23, 2021
Potential Implications of Mammalian Transient Receptor Potential Melastatin 7 in the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A ReviewStanley Du Preez, Helene Cabanas, Donald Staines, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 3, 2024
A pilot cross-sectional investigation of symptom clusters and associations with patient-reported outcomes in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Post COVID-19 ConditionBreanna Weigel, Natalie Eaton-Fitch, Kiran Thapaliya, et al.
Pageof 9